SAN JOSE, Calif. --(BUSINESS WIRE)--Apr. 19, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that it will release financial results for the first quarter of

Agreement designed to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System SAN JOSE, Calif. --(BUSINESS WIRE)--Apr. 17, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to

SAN JOSE, Calif. --(BUSINESS WIRE)--Apr. 15, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced its partnership with the American Nephrology Nurses Association

SAN JOSE, Calif. --(BUSINESS WIRE)--Mar. 13, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced the appointment of medical technology veteran Brent D.

SAN JOSE, Calif. --(BUSINESS WIRE)--Feb. 26, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that members of management will present at the 44 th annual TD

SAN JOSE, Calif. --(BUSINESS WIRE)--Feb. 21, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full

SAN JOSE, Calif. --(BUSINESS WIRE)--Feb. 5, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that it will release financial results for the fourth quarter and

SAN JOSE, Calif. --(BUSINESS WIRE)--Jan. 8, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today reported unaudited revenue for the fourth quarter and fiscal year ended

SAN JOSE, Calif. --(BUSINESS WIRE)--Jan. 3, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that members of management will present at the 42 nd annual J.P.